Evidence map›Paper›PMID 36483352›Full record

ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2022

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals.

Monica V Mahoney, Hita Bhagat, Robbie Christian, Carlos Del Rio, Kenneth C Hohmeier, Michael E Klepser, Jason M Pogue

Open access · goldAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 1 country.

Monica V MahoneyDepartment of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts.ORCID https://orcid.org/0000-0002-5071-2159
Hita BhagatDepartment of Pharmacy, Community Health Network, Indianapolis, Indiana.
Robbie ChristianBaton Rouge General, Baton Rouge, Louisiana.
Carlos Del RioDivision of Infectious Diseases, Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia.ORCID https://orcid.org/0000-0002-0153-3517
Kenneth C HohmeierDepartment of Clinical Pharmacy & Translational Science, University of Tennessee Health Science Center, Nashville, Tennessee.
Michael E KlepserFerris State University College of Pharmacy, Big Rapids, Michigan.ORCID https://orcid.org/0000-0001-9025-9099
Jason M PogueDepartment of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan.
Baton Rouge General · USBeth Israel Deaconess Medical Center · USCommunity Health Network · USEmory University · USFerris State University · USUniversity of Michigan · USUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although pharmacists are key members of the healthcare team, they are currently ineligible to independently prescribe the oral coronavirus disease 2019 (COVID-19) antivirals. We report the roles pharmacists have undertaken during the COVID-19 pandemic and provide evidence for the support of independent oral COVID-19 antiviral prescribing.

Identifiers

PMID36483352
PMCPMC9726491
OpenAlexW4285027740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.